Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients

Journal of Hypertension, Supplement

Volumn 14, Issue 6, 1996, Pages

  Cooper, Mark E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

ACE inhibitors; Albuminuria; Diabetes; Nephropathy; Perindopril; Proteinuria

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NIFEDIPINE; PERINDOPRIL;

BLOOD PRESSURE; CLINICAL TRIAL; CONFERENCE PAPER; DIABETES MELLITUS; DIABETIC NEPHROPATHY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; KIDNEY FUNCTION; LONG TERM CARE; META ANALYSIS; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTECTION;

ALBUMINURIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; HUMANS;

EID: 0030459148     PISSN: 09521178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (5)

1. Clark CM Jr. Lee DA: Prevention and treatment of the complications of diabetes mellitus.N Engl J erflQQS, 332:1210-1217.
2. Held PJ, Port FK, Webb RL, era/.: Excerpts from the United States Renal Data System 1995 Annual Data Report Am JKidney Dis 1990,4 (suppl 2): SI-SI 86.
3. Mogensen CE, Christensen CK, Vittinghus E: The stages in diabetic renal disease: with emphasis on the stage of incipient diabetic nephropathy. Diabetes 1983,32:64-78.
4. Gilbert R, Cooper ME, McNally PG, O'Brien RC, Taft J, Jerums G: Microalbuminuria: prognostic and therapeutic implications in diabetes mellrtus. Diabetic Med 1994,11 -.636-645.
5. Stein P, Black H: Drug treatment of hypertension in patients with diabetes mellitus. Q'afcefes Care 1991,14:425-448.